# Roche says it will acquire U.S.-based digital pathology and AI company PathAI in a deal worth up to $1.05 billion.

*biotech · news · 2026-05-07 · Benzinga*

## Key points

- Roche will acquire PathAI for up to $1.05 billion, including $750 million upfront.
- PathAI's Image Management System, AISight, will be integrated into Roche's oncology diagnostics platforms.
- PathAI's AI tools will expand Roche's capabilities in clinical trials and translational research support.
- The acquisition builds on a Roche-PathAI partnership first established in 2021 and expanded in 2024.
- Combined technologies are expected to accelerate biomarker discovery and personalized healthcare diagnostics.

**Companies:** Roche, PathAI
**Countries:** United States

[Read the full story on Benzinga](https://www.benzinga.com/m-a/26/05/52383978/roche-to-acquire-pathai-in-up-to-1-05-billion-deal-to-expand-digital-pathology-push)

---

Canonical: https://newsio.io/n/51e83cef-1e3e-41fa-bfe7-d0cfbc317ee3/roche-says-it-will-acquire-u-s-based-digital-pathology-and-ai-company-pathai-in
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works